Jeff Frelick
CIK: 0001645093
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBLG
Bone Biologics Corp
Officer
Discretionary Trading P&L
Holdings
About Frelick Jeff
Frelick Jeff (SEC CIK 0001645093) files insider reports with the SEC as Chief Executive Officer of Bone Biologics Corp (BBLG).
Signal8 holds 2 ownership filings by Frelick Jeff, all Form 4s, filed between Jan 21, 2025 and Jan 21, 2026. Those filings report 2 transactions, from Jan 15, 2025 to Jan 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Frelick Jeff's filings is in BURLINGTON,, MA.
Recent filings by Frelick Jeff
Other insiders filing for Bone Biologics Corp (BBLG)
- Walsh Deina H, Chief Financial Officer
- Meikle Phillip Terry II, Director
- Angle Siddhesh Rajendra, Director
- Stroever Bruce, Director
- Gagnon Robert E., Director